Wegovy Users Maintain Weight Loss for 4 Years: Here's How It Works

Updated Dec 3, 2024 | 09:00 PM IST

SummaryWegovy, is primarily an antidiabetic medication used to treat Type 2 diabetes. People receiving weight-loss drug Wegrovy sustained weight loss for up to four years
wegovy

wegovy (Credit: Canva)

People receiving weight-loss drug Wegovy sustained weight loss for up to four years, shedding an average of 10% of their body weight in that time, as per a new study. Wegrovy is a brand that markets semaglutide injections, that have gained widespread attention for their weight-loss effects. The study also found that Semaglutide injections boost an individual's heart health, even when weight loss doesn't take place.

The study, called SELECT, was published in journal Nature Medicine. "At four years, we see ongoing benefits of semaglutide," said Cheng-Han Chen, MD, interventional cardiologist from Cardiologist, who was not involved in the research. Besides the weight loss, it also lead to a loss in cardiovascular outcomes.

The research was conducted on 17000 adults, who had obesity but did not have diabetes. Overall, people who received once-weekly injections of semaglutide lost on average 10.2% of their body weight over the course of four years. All of the study participants continued to lose weight for about 65 weeks, a year and three months, and then their weight remained at a stable level.

Were There Any Side Effects?

However, people's experience with the medication varied. Researchers found no unexpected safety issues with drug during trial. In fact, most the people who withdrew from the study were those who experienced the known symptsoms of the semaglutide injections like nausea, indigestion etc. This occurred mainly during the beginning of the study, as the dose of the medicine is increased to a maximally tolerated dose.

What Did The Results Say?

Of the people on the highest dose of Wegovy, 68% lost at least 5% of their body weight. This compared to 21% of people on the placebo. Additionally, of the total people on Wegovy about 23% lost at least 15% of their body weight. For those in the placebo group, only 1.7% lost that much body weight.

Semaglutide Shows Heart Benefits Beyond Weight Loss

Researchers found that even individuals who did not experience significant weight reduction while on the drug saw a reduced risk of major heart events. Recent analysis of the SELECT trial data revealed that semaglutide significantly lowers the risk of heart attack, stroke, and cardiovascular-related deaths in adults with obesity or those who are overweight. Notably, the results of this study lead the US FDA to approve Novo Nordisk's Wegovy for reducing heart-related risks in this group.

What Is Semaglutide?

Semglutide is the synthetic version of GLP-1—a natural hormone produced in the intestines that regulates blood sugar, appetite, and digestion. Now, every time you eat, your body produces various hormones, including GLP-1. These are called Post nutrition hormones, and help you absorb the energy you just consumed. GLP-1 travels to your pancreas, prompting it to produce insulin. It also travels to the hypothalamus in your brain, which gives you the feeling of being full or satiated. Ozempic imitates this hormone, thereby, silencing the food chatter in the brain. Interestingly, for some people this food chatter is really quiet ( people with low appetite) and for others it is an outburst, (people who generally binge eat.) So with Ozempic, silencing this self-talk in the brain, people tend to lose their appetite and eventually weight.

Are Their Any Side Effects Of Semaglutide?

Semaglutide, marketed under the brand name Wegovy, is primarily an antidiabetic medication used to treat Type 2 diabetes. It is also an anti-obesity drug used for long-term weight management. While it can be taken as a subcutaneous injection or orally, it has significant side effects. It primarily impacts your gastrointestinal tract and its side effects include constipation, nausea, abdominal pain, diarrhoea, and fatigue amongst others.

End of Article

Delhi Sees Nearly 6x Rise In H1N1 Cases: How Is It Different From Other Respiratory Infections?

Updated Aug 10, 2026 | 05:10 PM IST

SummaryH1N1 is a subtype of Influenza A and can cause sudden fever, cough, sore throat, headache, body aches and fatigue. These symptoms can overlap with those of other seasonal influenza strains, COVID-19 and respiratory syncytial virus (RSV), making it difficult to identify the infection based on symptoms alone.
Delhi Sees Nearly 6x Rise In H1N1 Cases: How Is It Different From Other Respiratory Infections?

Credit: AI Image

Amid the ongoing monsoon season, Delhi-NCR is seeing a rise in H1N1 influenza cases, with Delhi reporting 1,344 cases so far this season.

The figure is nearly six times higher than the 229 H1N1 cases recorded during the same period last year, The Times of India reported.

According to health officials, Delhi recorded around 4,000 influenza cases last year, most of them caused by H3N2. This year, H1N1 is the dominant strain. Both H1N1 and H3N2 are subtypes of Influenza A and spread mainly through respiratory droplets.

What Is H1N1 and Why Is Testing Important?

H1N1 is a subtype of Influenza A and can cause sudden fever, cough, sore throat, headache, body aches and fatigue. These symptoms can overlap with those of other seasonal influenza strains, COVID-19 and respiratory syncytial virus (RSV), making it difficult to identify the infection based on symptoms alone.

Dr Aijaz Ilmi, Senior Consultant – Metabolic Diseases, Pacific OneHealth Hospital, told HealthandMe that testing is particularly important when fever or respiratory symptoms persist or worsen, especially among older adults, young children, pregnant women and people with diabetes, obesity, heart or lung disease, or compromised immunity.

“With the current rise in H1N1 cases in Delhi, we are also seeing other seasonal respiratory infections, including Influenza A and B, COVID-19, RSV and other respiratory viruses. At the same time, the monsoon season brings an increased risk of mosquito-borne illnesses such as dengue.

“The key message is, don’t panic, but don’t dismiss a persistent fever as ‘just a viral’. Early recognition is particularly important in vulnerable individuals.”

H1N1 vs Other Respiratory Infections: How Are They Different?

H1N1 can be difficult to distinguish from other respiratory infections because many of them cause similar symptoms.

  • H1N1 and other seasonal influenza strains: Both can cause sudden fever, cough, sore throat, headache, body aches and fatigue. Symptoms alone generally cannot determine whether the infection is H1N1 or another influenza strain.
  • COVID-19: COVID-19 can cause fever, cough, sore throat, congestion and fatigue. Some people may also experience changes in or loss of taste or smell, while gastrointestinal symptoms can occur.
  • RSV: RSV commonly causes a runny nose, cough and wheezing. It can be more severe in infants, older adults and people with certain underlying conditions. In young children, it can cause bronchiolitis and breathing difficulties.
  • Dengue: During the monsoon, dengue can also cause fever, headache, body aches and fatigue, which may initially resemble a viral respiratory infection. However, dengue is spread by mosquitoes rather than respiratory droplets and does not typically cause cough or sore throat.
Dr Amit Prakash Singh, Consultant - Internal Medicine at The CK Birla Hospital, Delhi, told HealthandMe that because symptoms overlap, they cannot confirm the infection. Molecular or antigen-based tests can help identify the virus, particularly in high-risk patients or those with severe or persistent symptoms.

How Can H1N1 and Other Infections Be Prevented?

Dr Sharwari Sudhir Dabhade, Consultant - Internal Medicine, Diabetology & Endocrinology, Madhukar Rainbow Children's Hospital, told HealthandMe that prevention should focus on reducing exposure and maintaining good hygiene. Other measures to reduce transmission include:

  • Washing hands frequently.
  • Covering mouth and nose while coughing or sneezing.
  • Maintaining good indoor ventilation.
  • Avoiding crowded or poorly ventilated places when respiratory infections are circulating.
  • If you have respiratory symptoms, limit close contact with others and wear a mask.
  • Getting vaccinated against influenza, particularly if you are an older adult, young child or have an underlying health condition.
  • Prevent mosquito breeding and take precautions to avoid mosquito bites to reduce risk of dengue.

When Should You Seek Medical Help?

Most viral respiratory infections recover with supportive care. However, should seek prompt immediate medical assessment in cases of

  • breathlessness
  • persistent high fever,
  • chest pain,
  • confusion,
  • dehydration,
  • falling oxygen saturation
  • significant worsening of weakness.

End of Article

The Gut-Brain Connection: Study Says IBD Patients May Experience Depression & Anxiety Years Before Diagnosis

Updated Aug 10, 2026 | 04:00 PM IST

SummaryA recent study indicates that patients with inflammatory bowel disease are more likely to get diagnosed with mental health issues like depression and anxiety
IBD Linked To Higher Risk Of Depression And Anxiety Years Before Diagnosis

Credit: AI

People with inflammatory bowel disease (IBD) may face a higher risk of depression, anxiety and other psychiatric disorders years before they are diagnosed with the gut condition, a new study has discovered.

The study, published in Clinical Gastroenterology and Hepatology, found that the risk of psychiatric disorders began rising two to three years before an IBD diagnosis, peaked shortly after diagnosis and remained elevated for as long as a decade.

Researchers from Karolinska Institutet and other Swedish institutions analysed data from 43,862 people with IBD, comparing them with nearly 179,000 individuals from the general population and more than 26,000 IBD-free full siblings.

The sibling comparison was key as it helped researchers examine whether shared genetic or early-life environmental factors could explain any association.

Risk Of Mental Health Issues Increase Before IBD Diagnosis

Also read: Monsoon Gut Health: Addressing The Rise In Rotavirus And Viral Gastroenteritis Cases

The study found that the risk of developing any mental health disorder was already 15% higher two years before IBD diagnosis. It increased further around the time of diagnosis, reaching a roughly 50% higher risk within the first six months.

Although the risk reduced afterwards, it remained about 19% higher even 10 years after diagnosis. Major depressive disorder, anxiety disorders and substance misuse accounted for much of the increase.

Antidepressant and anti-anxiety medication use also began rising around a year before the IBD diagnosis.

Researchers called for mental health screening to begin early, including during the initial gastroenterology evaluation.

“It is time to actively manage psychiatric conditions in patients with IBD,” said Jiangwei Sun, PhD, the study’s lead author.

Why Depression And Anxiety Appear Before IBD Is Diagnosed?

Also read: Following A Western Diet? Changes In Your Gut Bacteria Could Increase Colon Cancer Risk

IBD includes Crohn’s disease and ulcerative colitis, autoimmune conditions that cause inflammation in the digestive tract.

One possible explanation is the gut-brain axis, the two-way communication system connecting the digestive system and brain.

Inflammation, changes in gut bacteria and abnormal immune activity may affect brain function and overall mood. At the same time, stress and psychological distress can affect the gastrointestinal symptoms.

But researchers caution that the study merely shows an association, not proof that IBD directly causes depression or anxiety.

Some people may experience subtle or unexplained gastrointestinal symptoms before receiving an official diagnosis, while the uncertainty and disruption caused by chronic symptoms could also affect mental health.

Mounting Evidence

The findings follow previous research that shows psychiatric symptoms can surface before the patient is diagnosed with IBD.

A 2023 study examining longitudinal health records found that anxiety and depression occurred more frequently among people who were later diagnosed with IBD.

In a 2024 systematic review and meta-analysis, it was observed that patients with a history of depression may have a small-to-moderate increased risk of subsequently developing IBD, suggesting that the relationship between the gut and mental health could work in both directions.

The new findings therefore signal that mental health symptoms may sometimes arrive years before IBD itself is formally diagnosed in patients.

For doctors, researchers say this highlights the need to treat IBD as more than a digestive disease, with psychological support and screening considered part of long-term care.

End of Article

Lymphedema Is More Than Just Swelling: Why Early Treatment Can Make A Difference

Updated Aug 10, 2026 | 02:00 PM IST

SummaryLymphedema causes more than swelling, potentially leading to pain, skin changes, and infections. Early diagnosis and treatment can control symptoms, prevent complications, and improve quality of life.
Lymphedema Is More Than Just Swelling: Why Early Treatment Can Make a Difference

Credit: AI

Many people may dismiss swelling in an arm or leg, particularly if it's not painful. But if the swelling continues or keeps coming back, it could be a sign of lymphedema, a condition that affects the body's lymphatic system.

The lymphatic system is responsible for draining excess fluid from body tissues. If this system is damaged or is not functioning correctly, fluid will accumulate, and lead to swelling. There are different causes of lymphedema such as some infections, injuries, congenital disorders and cancer therapies. Women who have had breast or gynaecological cancers may be at special risk if they had their lymph nodes removed or if radiation had been used.

What are the WARNING SIGNS?

Sometimes, lymphedema develops gradually. Signs and symptoms include swelling of one arm or leg, heaviness or tightness in the arm or leg, trouble putting on rings or a watch, and decreased movement in the arm or leg.

At times, the skin can also be tight and turn into a hard consistency over time. In certain patients, a second infection of the skin may occur.

These symptoms should not just be attributed to "normal swelling. An early evaluation may help determine the root cause and make the condition less complicated to deal with.

Also read: Full-Fat Dairy May Actually Be Healthy, Not Harm Weight or Cholesterol, Study Finds

What Is The Treatment For Lymphedema?

Treatment will depend on the severity of the disease and its etiology. Treatment usually involves compression garments, special physiotherapy, gentle lymphatic massage, exercises and skin care. The techniques may be used to help decrease swelling and movement.

Surgery may be necessary in some cases of more severe or chronic lymphedema. New pathways can be created to allow the excess fluid to pass, such as in a lymphovenous bypass. For some patients, a transfer of lymph nodes or liposuction may be an option.

Additionally, for patients who have an increased risk of developing lymphedema, doctors may also recommend preventive measures for individuals who must have some type of cancer surgery. This implies that measures should be taken to ensure protection of the lymphatic drainage before any appreciable swelling occurs.

Also read: NIH Chief Urges Parents To Vaccinate Children As Measles Outbreak Breaks 35 Year Record

When To Go To The Doctor?

If swelling isn't severe, don't wait to get help. If there is any continued or unexplained swelling, there will be a specialist available to give information about the cause of the swelling and what treatment is appropriate.

Patients are provided with a holistic treatment pathway for lymphedema with multiple specialists treating their patients who came together for the diagnosis, rehabilitation and surgical treatment of lymphedema.

Treatment of lymphedema is not all about reducing swelling. The overall aim is to maintain a person's function, ease and independence in their daily activities.

If diagnosed early, and appropriately treated and followed-up, lymphedema can be managed successfully and patients can lead their life with a growing sense of confidence and comfort.

End of Article